---
aliases: /news/sequel-systems-announces-e-prescribing-for-controlled-substances
archetype: press-release
author:
  - Radhika Narayanan
basePath: /news/
breadcrumbLinks:
  - /
  - /news/
  - ''
breadcrumbs:
  - Home
  - News
  - Sequel Systems Announces E-prescribing For Controlled Substances
categories:
  - 'Medigy: Media (Press) Release'
  - 'Healthcare IT News: Opioid Prescribing'
categorySlug:
  - 'medigy: media (press) release'
  - 'healthcare it news: opioid prescribing'
categoryUrl:
  - topic/medigy-media-press-release
  - topic/healthcare-it-news-opioid-prescribing
categoryLabel:
  - Media (Press) Release
  - Opioid Prescribing
contentCategories: netspective-medigy-news-curated-content
institution:
  - id: 12037
    title: SequelMed®
    description: >-
      SequelMed®, founded in 1995, is a privately held, dynamic medical software
      company headquartered in Melville, NY. Our integrated line of software
      products Practice Management and EHR as well as healthcare IT solutions,
      business services, and technical support cater to physician practices,
      health organizations, hospitals, and billing companies.


      To meet the critical challenge of simplifying the complex medical records,
      healthcare IT needed a solid foundation to achieve quality outcomes. To
      achieve this end SequelMed brings together a dedicated team of
      professionals and leading industry partners and the result is a company
      with a diverse product portfolio that is now revolutionizing healthcare.
    alias: /profile /offeror/institution/sequelmed-r
    slug: sequelmed-r
    url: /profile/offeror/institution/sequelmed-r
    logo: 12037-logo.JPEG
offering: null
layOut: news-press-release-single
date: '2022-09-13'
description: >-
  April 19, 2017Sequel Systems earns electronic prescriptions for controlled
  substances (EPCS) certification, improving provider workflow and patient
  safety.MELVILLE, NY - April 19, 2017 - Sequel System
favIconImage: null
featuredImage:
  alt: Sequel Systems Announces E-prescribing For Controlled Substances
  format: JPEG
  href: 64a5be05-2de5-5c07-a799-4458cce3257e-featuredImage.jpeg
  size:
    - 300
    - 590
  valid: true
  workPackage: 14852
  wpAttachment:
    fileName: Curated_Featured_Image.jpg
    link: /api/v3/attachments/27305/content
featuredPdf: null
htmlMetaData:
  author: null
  description: Sequel Systems Announces E-Prescribing for Controlled Substances
  generator: null
  viewport: 'width=device-width, initial-scale=1'
  articlemodified_time: null
  articlepublished_time: null
  msvalidate.01: null
  ogdescription: null
  ogimage: null
  ogsite_name: null
  ogtitle: null
  ogtype: null
  ogupdated_time: null
  ogurl: null
  yandex-verification: null
  robots: null
  fbapp_id: null
  oglocale: null
  fbadmins: null
  articlepublisher: null
  google-site-verification: null
  keywords: null
id: 14852
identifier: News
lastMod: '2022-09-13T19:53:16.164554Z'
link:
  brand: sequelmed.com
  href: >-
    https://www.sequelmed.com/press-releases/sequel-systems-announces-eprescribing-for-controlled-substances.aspx
  original: >-
    https://www.sequelmed.com/press-releases/sequel-systems-announces-eprescribing-for-controlled-substances.aspx
href: >-
  https://www.sequelmed.com/press-releases/sequel-systems-announces-eprescribing-for-controlled-substances.aspx
original: >-
  https://www.sequelmed.com/press-releases/sequel-systems-announces-eprescribing-for-controlled-substances.aspx
mastHead: NEWS
mdName: 64a5be05-2de5-5c07-a799-4458cce3257e.md
openGraphMetaData:
  ogdescription: null
  ogtitle: null
  ogurl: null
  ogimage: null
  ogsite_name: null
  ogtype: null
  ogupdated_time: null
  ogimageheight: null
openProjectCustomFields:
  cleanUrl: >-
    https://www.sequelmed.com/press-releases/sequel-systems-announces-eprescribing-for-controlled-substances.aspx
  medigyTopics:
    - 'Medigy: Media (Press) Release'
    - 'Healthcare IT News: Opioid Prescribing'
  sourceUrl: >-
    https://www.sequelmed.com/press-releases/sequel-systems-announces-eprescribing-for-controlled-substances.aspx
openProjectWorkPackageType: Press Release
searchCategory: News
slug: sequelmed-sequel-systems-announces-e-prescribing-for-controlled-substances
source: open-project-curations
status: ''
sub: brief
tags:
  - News
title: Sequel Systems Announces E-prescribing For Controlled Substances
via: ' '
insights_description: null
insights_name: null
viaLink: null
relatedOfferings:
  - label: OpiSafe's Solutions for Opiod Crisis
    permalink: /offering/opisafes-solutions-for-opiod-crisis
    categories:
      - 'Healthcare IT News: Opioid Prescribing'
    offeringId: 6421
  - label: Innovaccer’s Cures 2.0
    permalink: /offering/innovaccers-cures-2-0
    categories:
      - 'Healthcare IT News: Opioid Prescribing'
      - 'Medigy: Medication Management'
    offeringId: 5734
twitterMetaData:
  twittercard: null
  twitterdescription: null
  twittertitle: null
  twitterimage: null
  twitterurl: null
---
<p>April 19, 2017</p><p><i>Sequel Systems earns electronic prescriptions for controlled substances (EPCS) certification, improving provider workflow and patient safety.</i></p><p><strong>MELVILLE, NY - April 19, 2017 - </strong><a href="http://www.sequelmed.com/">Sequel Systems, Inc.</a>, a healthcare IT company, today announced their EPCS certification for their electronic health record (EHR), SequelMed®. The certification allows e-prescribing for Schedule II through V controlled substances from within SequelMed® EHR.</p><p>Sequel Systems completed the certification in compliance with the Drug Enforcement Administration’s (DEA’s) Interim Final Rule (IFR) Title 21 CFR Part 1311, a regulation that permits e-prescribing for controlled substances and drives more efficient and secure processes.</p><p>“EPCS provides a safe and convenient way for physicians to prescribe scheduled medications electronically, and improves patient safety by reducing medication errors, prescription fraud and abuse,” said Khurshid Mughal, chief executive officer at Sequel Systems. “We are pleased to announce our EPCS certification and offer e-prescribing to help our clients deliver better, safer and faster care.”</p><p>All applications used for e-prescribing controlled substances must undergo testing and certification through a third-party auditor, required by the DEA. Sequel Systems’ testing and certification was completed by Drummond Group, one of the first DEA-approved certification organizations.</p><p>“We chose to complete our certification with Drummond Group, one of the most experienced software testing and certification labs in the nation,” said Mughal. “Their expert-driven and detailed certification process ensures we can deliver EPCS to our clients with confidence.”</p><p>“Drummond Group’s <a href="https://www.drummondgroup.com/services/epcs-certification">certification process</a> is backed by expertise and coupled with a customer-friendly approach, where we walk our customer through a complete requirements review, provide dry run testing with gap analysis and final certification,” said Aaron Gomez, director of EPCS certification at Drummond Group. “We congratulate Sequel Systems on completing their EPCS certification.”</p><p>In compliance with DEA IFR Title 21 CFR Part 1311, all clinicians e-prescribing within SequelMed® EHR will be required to review Sequel Systems’ certification report and the <a href="https://www.deadiversion.usdoj.gov/21cfr/cfr/1311/subpart_c100.htm">DEA’s EPCS requirements</a>. Clients who want to activate this functionality can call 800-965-2728 to speak with a Sequel Systems support team member.</p><p><strong>About Drummond Group</strong>&nbsp;<br>Drummond Group is a global software test and certification lab that serves a wide range of vertical industries. In healthcare, Drummond Group tests and certifies <a href="https://www.drummondgroup.com/services/csos-audit-services">Controlled Substance Ordering Systems (CSOS)</a>, <a href="https://www.drummondgroup.com/services/epcs-certification">Electronic Prescription of Controlled Substances (EPCS) </a>software and processes, and <a href="https://www.drummondgroup.com/services/ehr-healthcare-services">Electronic Health Records (EHRs)</a> - designating the trusted test lab as the only third-party certifier of all three initiatives designed to move the industry toward a digital future. Founded in 1999, and accredited for the Office of the National Coordinator HIT Certification Program as an Authorized Certification Body (ACB) and an Authorized Test Lab (ATL), Drummond Group continues to build upon its deep experience and expertise necessary to deliver reliable and cost-effective services. For more information, please visit http://www.drummondgroup.com or email epcs@drummondgroup.com.</p><p><strong>About Sequel Systems</strong>&nbsp;<br>Sequel Systems, founded in 1995, is a healthcare IT company that specializes in solutions for hospitals, health organizations, physician practices and billing companies. The company’s flagship solution, SequelMed, an electronic health record (EHR) and practice management solution (PM), is trusted by more than 15,000 physicians. Sequel Systems has also been recognized as a finalist for the Hauppauge Industrial Association’s Business Achievement Awards (September 2009) and Long Island Business Association's Healthcare Heroes Awards (December 2009). For more information about Sequel Systems visit <a href="http://www.sequelmed.com/">www.sequelmed.com</a>.</p><p><strong>Media Contact:</strong>&nbsp;<br>Kaitlyn Herron<br>Marketing Manager<br>Sequel Systems&nbsp;<br>(469) 573-3406<br><a href="mailto:Kaitlyn@SequelMed.com">Kaitlyn@SequelMed.com</a></p><p><a href="https://www.sequelmed.com/media.aspx">Back to Press Releases &amp; Articles</a></p><p>&nbsp;</p>